Girls with acute lymphoblastic leukemia recovered in AMH during maintenance treatment, whereas AMH levels in girls who received pelvic radiation or stem cell transplantation (SCT) remained undetectable at a median follow-up time of 18 months.[12] A study on adult patients reported a decline in AMH after just 1 week of treatment for breast cancer, Ewing sarcoma (ES), and lymphoma.[14]. This evidence concerns the gene AMH and breast carcinoma.